Iris Metastasis Regression Following Osimertinib Treatment

JAMA Ophthalmol. 2020 Dec 1;138(12):e202095. doi: 10.1001/jamaophthalmol.2020.2095. Epub 2020 Dec 10.

Authors

Kuan-Jen Chen^{1

2}, An-Ning Chao^{1

2}, Chih-Liang Wang^{2

3}

Affiliations

¹ Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
² College of Medicine, Chang Gung University, Taoyuan, Taiwan.
³ Department of Thoracic Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.

PMID: 33300967
DOI: 10.1001/jamaophthalmol.2020.2095

No abstract available

Publication types

Case Reports

MeSH terms

Acrylamides / administration & dosage*
Adenocarcinoma of Lung / diagnosis
Adenocarcinoma of Lung / drug therapy
Adenocarcinoma of Lung / secondary*
Aged
Aniline Compounds / administration & dosage*
Antineoplastic Agents / administration & dosage
Female
Humans
Iris / pathology*
Iris Neoplasms / diagnosis
Iris Neoplasms / drug therapy*
Iris Neoplasms / secondary
Lung Neoplasms / diagnosis*
Lung Neoplasms / drug therapy
Neoplasm Metastasis
Slit Lamp Microscopy

Substances

Acrylamides
Aniline Compounds
Antineoplastic Agents
osimertinib